Double-blind, placebo-controlled trial of octreotide long-acting repeatable (LAR) in thyroid-associated ophthalmopathy
収録刊行物
-
- J Clin Endocrinol Metab
-
J Clin Endocrinol Metab 89 5910-5915, 2004